ID   ACB-885
AC   CVCL_M487
SY   ACB885
DR   Wikidata; Q54608097
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1980237;
RX   PubMed=3472643;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~30-35 hours (PubMed=3472643).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M488 ! ACB-1085
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=1980237;
RA   Fourney R.M., Palmer M., Ng A., Dietrich K.D., Belch A.R., Paterson M.C.,
RA   Brox L.W.;
RT   "Elevated c-myc messenger RNA in multiple myeloma cell lines.";
RL   Dis. Markers 8:117-124(1990).
//
RX   PubMed=3472643; DOI=10.1016/0165-4608(87)90268-8;
RA   Brox L.W., Belch A.R., Pollock E., He X.X., De Braekeleer M., Lin C.-C.;
RT   "Cytogenetic and biological characterization of two new human plasma
RT   cell lines.";
RL   Cancer Genet. Cytogenet. 27:135-144(1987).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//